Affiliation: National Research Council Canada, Human Health Therapeutics Research Centre

Kelly Fulton is a research scientist at the National Research Council Canada’s Human Health Therapeutics Research Centre (NRC-HHT). Kelly holds a BSc (Hons) degree in Biotechnology from the University of Ottawa (Ottawa, ON Canada) and is completing a PhD in Biochemistry at Carleton University (Ottawa, ON Canada). Her graduate research has focussed upon the development and application of methods to discover and characterize the bacterial glycoproteome. At NRC-HHT, she leads research projects in bacterial proteomics, supporting antimicrobial preparedness and vaccine development. Kelly has also led research into the application of mass spectrometry approaches for the improved characterization of complex protein- and viral-based therapeutics. In addition to research, Kelly has focussed on the development of early-career researchers, mentoring numerous undergraduate students.  Kelly has authored over 30 publications and book chapters. She has also served as an editor for two books.